|
|||
| |||||||||||||||||||||||||||||||||||||||||||||
Patients with sickle cell disease are often routinely given folate supplementation. The rationale is to prevent the deficiency caused by the increased folate turnover in chronic hemolytic anemia.8 However, clinical folate deficiency rarely occurs in patients with sickle cell disease, and objective evidence of a benefit from such supplementation is sparse.9 The use of
Case Report
Discussion
Source Information
From the Department of Medicine (M.D., R.B., R.C.) and the Comprehensive Sickle Cell/Thalassemia Program (R.B.), New York Methodist Hospital, Brooklyn, N.Y.; and the Department of Medicine, Weill Medical College of Cornell University, New York (R.C.).
Address reprint requests to Dr. Carmel at New York Methodist Hospital, 506 Sixth St., Brooklyn, NY 11215, or at rac9001@nyp.org.
Related Letters:
Folate Supplementation in Sickle Cell Anemia
Hoffer L. J., Carmel R.
Extract |
Full Text |
PDF
N Engl J Med 2003;
349:813, Aug 21, 2003.
Correspondence
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |